CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


08-July-2014
New Stable-Labeled Therapeutic Drug Monitoring (TDM) Internal Standards from Cerilliant - Gabapentin-13C3 & Fluconazole-13C3.

Fluconazole-13C3, 1.0 mg/mL, F-035
1.0 mg/mL in Methanol

A stable-labeled internal standard suitable for quantification of fluconazole levels in blood, serum, or plasma by HPLC or LC-MS/MS. Fluconazole, sold under trade names such as Trican®, Monicure®, Diflucan®, and Afungil®, is an antifungal drug used in the treatment and prevention of superficial and systemic fungal infections.

Gabapentin-13C3, 100 ug/mL, G-018
100 µg/mL in Methanol

Sold under the trade names Neurontin®, Nupentin®, or Gabarone®, gabapentin is an anticonvulsant drug used primarily for treatment of seizures, fibromyalgia, and neuropathic pain. This internal standard is suitable for mass spectrometry-based testing or isotope dilution methods of gabapentin in forensic analysis, clinical toxicology, pain prescription monitoring, or urine drug testing applications.



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn